Abstract:
The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2025 annual meeting
featured a session on geographic variations in psoriasis (PsO) and psoriatic arthritis (PsA) care, integrating
patient and clinician perspectives from Kenya, Singapore, the US, Colombia, and Türkiye. Presentations
addressed disparities in diagnosis, treatment access, workforce capacity, and patient experiences shaped by
socioeconomic and cultural contexts. Regional data revealed underdiagnosis of PsA, urban-rural inequities,
and inconsistent use of composite disease activity measures. Economic constraints, health system structure,
and cultural factors influenced both clinical outcomes and quality of life. Across regions, common challenges
included workforce shortages, high treatment costs, diagnostic delays, and unmet mental health needs. A
patient testimony from Kenya highlighted extreme cost barriers to biologics and limited specialist avail-
ability. The session underscored the importance of global collaboration to improve access, equity, and cultur-
ally informed care for individuals living with PsO and PsA